Ftse Mib
33.731,96
1,27%
DAX
18.285,22
0,55%
S&P 500
5.464,62
-0,16%
NASDAQ
17.689,36
-0,18%
Bitcoin
60.903,53
-3,57%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE K V Pharma CL B (KVB) K V Pharma CL B (KVB) Notizie

KVB

K V Pharma CL B (KVB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:KVB
DataOraFonteTitoloSimboloCompagnia
18/06/201215:04Dow Jones NewsU.S. HOT STOCK FUTURES: HOT STOCKS to WATCHNYSE:KVBK V Pharma CL B
17/11/201102:15Business WireGlancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
03/11/201102:40Business WireLaw Offices of Howard G. Smith Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
01/11/201102:30Business WireGlancy Binkow & Goldberg LLP Announces Class Action Lawsuit Against K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
28/10/201122:30Business WireFaruqi & Faruqi, LLP Announces Investigation of K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
24/10/201119:52Business WireThe Briscoe Law Firm and Powers Taylor, LLP Announce Investigation of K-V Pharmaceutical CompanyNYSE:KVBK V Pharma CL B
13/06/201114:00PR Newswire (US)K-V Pharmaceutical Company Announces Filing of Fiscal 2011 Form 10-K and Schedules Investor Conference CallNYSE:KVBK V Pharma CL B
01/04/201121:08Dow Jones NewsUPDATE: K-V Pharma Slashes Price Of Preterm Labor Drug Amid OutcryNYSE:KVBK V Pharma CL B
01/04/201116:28Dow Jones NewsK-V Pharma Slashes Prices Of Preterm Labor Drug After FDA MoveNYSE:KVBK V Pharma CL B
31/03/201123:28Dow Jones NewsReligious Groups Urge Drug Makers To Ease Up On Price HikesNYSE:KVBK V Pharma CL B
30/03/201121:58Dow Jones NewsUPDATE: K-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVBK V Pharma CL B
30/03/201118:38Dow Jones NewsK-V Pharma Shares Drop On FDA Statement On Preterm Birth DrugNYSE:KVBK V Pharma CL B
01/03/201114:49PR Newswire (US)K-V Pharmaceutical Company Announces $200 Million Private Debt OfferingNYSE:KVBK V Pharma CL B
14/02/201116:34PR Newswire (US)K-V Pharmaceutical Company Announces Reliance on the Financial Distress Exception to NYSE's Shareholder Approval Policy to IssueNYSE:KVBK V Pharma CL B
14/02/201115:48PR Newswire (US)K-V Pharmaceutical Company Announces Completion of a $32 Million Private Placement of Class A Common StockNYSE:KVBK V Pharma CL B
04/02/201114:40PR Newswire (US)K-V Pharmaceutical Company to Host Investor Conference Call on February 14, 2011NYSE:KVBK V Pharma CL B
12/01/201115:03PR Newswire (US)K-V Pharmaceutical Company Updates Status of New Drug Application for Gestiva™NYSE:KVBK V Pharma CL B
14/09/201016:29Dow Jones NewsK-V Pharmaceutical Enters Loan Agreement In Wake Of FDA ApprovalNYSE:KVBK V Pharma CL B
10/09/201015:53Dow Jones NewsK-V Pharma Soars On FDA Approval To Return Product To MarketNYSE:KVBK V Pharma CL B
20/01/201021:41Dow Jones NewsUPDATE: Watson Pharma Benefits From Toprol Market PresenceNYSE:KVBK V Pharma CL B
20/01/201020:11Dow Jones NewsWatson Pharma Continues To Benefit From Toprol Market PresenceNYSE:KVBK V Pharma CL B
11/01/201015:18PR Newswire (US)KV Pharmaceutical Amends Agreement to Secure Rights to Gestiva(TM)NYSE:KVB
07/01/201022:10PR Newswire (US)KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes to Approve Appointment of DirectorNYSE:KVB
15/12/200923:26PR Newswire (US)KV Pharmaceutical Sets Record Date for Stockholder Action by Written ConsentNYSE:KVB
02/12/200922:45PR Newswire (US)KV Pharmaceutical Enters Into Employment Agreement with Interim President and Chief Executive Officer David A. Van VlietNYSE:KVB
13/11/200922:01PR Newswire (US)KV Pharmaceutical Receives Report From Inspector of Elections Certifying Votes To Approve Bylaw AmendmentsNYSE:KVB
07/10/200919:54Dow Jones NewsLarge Generic Drug Cos Benefiting From Price StabilityNYSE:KVBK-V Pharmaceutical Co. (Cl B)
21/09/200914:30PR Newswire (US)KV Pharmaceutical Divests ANDA for Generic Version of Duac(R)NYSE:KVB
15/09/200922:34PR Newswire (US)KV Pharmaceutical Receives Stockholder Action by Written ConsentNYSE:KVB
04/09/200923:43PR Newswire (US)KV Pharmaceutical Appoints Interim Chief Financial OfficerNYSE:KVB
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NYSE:KVB

La tua Cronologia

NASDAQ
AAYWEXX
Bofa Finance Llc Autocal...
TSXV
WII
ASX
OILR
Optiscan Imaging
USOTC
PALAF
Paladin Energy (QX)
LSE
QO88
Morg.st.b.v 24
TG
EJR
East Japan Railway
USOTC
PROIF
Prophecy (PK)
BIT
UB956W
Unicredit Bank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network